scholarly journals Phenotypic Variations of Mild-to-Moderate Obstructive Pulmonary Diseases According to Airway Inflammation and Clinical Features

2021 ◽  
Vol Volume 14 ◽  
pp. 2793-2806
Author(s):  
Małgorzata Proboszcz ◽  
Krzysztof Goryca ◽  
Patrycja Nejman-Gryz ◽  
Tadeusz Przybyłowski ◽  
Katarzyna Górska ◽  
...  
2020 ◽  
Vol 34 (3) ◽  
pp. 1291-1299
Author(s):  
Elizabeth A. Lee ◽  
Lynelle R. Johnson ◽  
Eric G. Johnson ◽  
William Vernau

Author(s):  
Małgorzata Proboszcz ◽  
Patrycja Nejman-Gryz ◽  
Magdalena Paplińska-Goryca ◽  
Katarzyna Górska ◽  
Rafał Krenke ◽  
...  

Author(s):  
Alexandru Corlateanu ◽  
Serghei Covantev ◽  
Victor Botnaru ◽  
Silvia Dumitru ◽  
Olga Corlateanu

: Obstructive pulmonary diseases are a group of respiratory conditions characterized by airflow limitation. They are prevalent in the population and lead to significant morbidity and mortality. The two most commonly encountered conditions are asthma and chronic obstructive pulmonary disease (COPD). Although, for many years the two conditions were regarded as separate it was realized that some patients may have an overlap between these illnesses. This observation lead to identification of asthma-COPD overlap (ACO) syndrome. ACO is an umbrella term that is used “to collectively describe patients who have persistent airflow limitation together with clinical features that are consistent with both asthma and COPD”. Its importance in the field of respiratory medicine is increasing every year as there are more data that underline the importance of its timely diagnosis and management. The current review is a timely update of the advances in our understanding of ACO.


2005 ◽  
Vol 115 (2) ◽  
pp. S175
Author(s):  
P. Prince ◽  
L.P. Boulet ◽  
H. Turcotte ◽  
P. Bégin ◽  
C. Lemière ◽  
...  

2006 ◽  
Vol 100 (2) ◽  
pp. 292-299 ◽  
Author(s):  
Louis-Philippe Boulet ◽  
Philippe Prince ◽  
Hélène Turcotte ◽  
Catherine Lemière ◽  
Ronald Olivenstein ◽  
...  

2016 ◽  
Vol 71 (3) ◽  
Author(s):  
S. Dragonieri ◽  
O. Tongoussouva ◽  
A. Zanini ◽  
A. Imperatori ◽  
A. Spanevello

During recent years there has been a growing interest in using non-invasive biomarkers to understand and monitor the airway inflammation in subjects with respiratory tract disorders. To date, the best validated and performing non-invasive biomarkers are measures of inflammation in induced sputum in both cellular and fluid phase, which can provide biological insights into the pathogenesis of respiratory diseases such as asthma and chronic obstructive pulmonary disease. The purpose of this review is to examine the principal literature on the different markers of inflammation in pulmonary diseases assessed by induced sputum analysis in either cellular or fluid phase.


Sign in / Sign up

Export Citation Format

Share Document